Identification of disease biomarkers by profiling of serum proteins using SELDI-TOF mass spectrometry

Methods in Molecular Biology

Volumn 439, Issue , 2008, Pages 191-197

  Langbein, Sigrun ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biomarker; Fractionated serum; Mass spectrometry (MS); Peptide mass fingerprinting (PMF); ProteinChip; Serum; Surface enhanced laser desorption ionization (SELDI); Time of flight (TOF)

Indexed keywords

EID: 84934443113     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-188-8_13     Document Type: Article

References (20)

1. Seet BT, Dikic I, Zho, MM, Pawson T (2006) Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 7:473-483
2. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
3. Gretzer MB, Partin AW, Chan DW, Veltři RW (2003) Modern tumor marker discovery in urology: Surface enhanced laser desorption and ionization (SELDI). Rev Urol 5:81-89
4. Ciordia S, de Los Rios V, Albar JP (2006) Contributions of advanced proteomics technologies to cancer diagnosis. Clin Transi Oncol 8:566-580
5. Wiesner A (2004) Detection of tumor markers with ProteinChip technology Curr Pharm Biotechnol 5:45-67
6. Xiao Z, Prieto D, Conrads TP, Veenstra TD, Issaq HJ (2005) Proteomic patterns: Their potential for disease diagnosis, Mol Cell Endocrinol 230:95-106
7. Zhang, H, Kong B, Qu X, Jia L, Deng B, Yang Q (2006) Biomarker discovery for ovarian cancer using SELDI-TOF-MS. Gynecol Oncol 102:61-66
8. Pusztai L, Gregory BW, Baggerly KA, Peng B, Koomen J, Kuerer HM, Esteva FJ, Symmans WF, Wagner P, Hortobagyi GN, Laronga C, Semmes OJ, Wright G L Jr, Drake RR, Vlahou A (2004) Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer 100:1814-1822
9. Miguet L, Bogumil R, Decloquement P, Herbrecht R, Potier N, Mauvieux L, Van DA (2006) Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS. J Proteome Res 5:2258-2269
10. Yip TT, Lomas L (2002) SELDI ProteinChip array in oncoproteomic research Technol Cancer Res Treat 1:273-280
11. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577
12. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H, Celis JE (1997) Proteome profiling of bladder squamous cell carcinomas: Identification of markers that define their degree of differentiation. Cancer Res 57:4111-4117
13. Anderson NL, Anderson NG (2002) The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 1:845-867
14. Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, Veenstra TD, Adkins JN, Pounds JG, Fagan R, Lobley A (2004) The human plasma proteome: A nonredundant list developed by combination of four separate source. Mol Cell Proteomics 3:311-326
15. Issaq HJ, Conrads TP, Prieto DA, Tirumalai R, Veenstra TD (2003) SELDI-TOF MS for diagnostic proteomics. Anal Chem 75:148A-155A
16. Chapman K (2002) The ProteinChip Biomarker System from Ciphergen Biosystems: A novel proteomics platform for rapid biomarker discovery and validation. Biochem Soc Trans 30:82-87
17. Langbein S, Lehmann J, Harder A, Steidler A, Michel MS, Aiken P, Badawi JK (2006) Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique. Technol Cancer Res Treat 5:67-72
18. Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Moller U, Osterloh D, Halbhuber KJ, von Eggeling F. (2004) A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res 64:4099-4104
19. Pusch W, Flocco MT, Leung SM, Thiele H, Kostrzewa M (2003) Mass spectrometry-based clinical proteomics. Pharmacogenomics 4:463-476
20. Fung ET, Weinberger SR, Gavin E, Zhang F (2005) Bioinformatics approaches in clinical proteomics. Expert Rev Proteomics 2:847-862